Strain Information | |
---|---|
Image | |
BRC No. | RBRC02850 |
Type | Transgene |
Species | Mus musculus |
Strain name | FVB/N-Tg(Alb-Ppp1r15a)14Dron |
Former Common name | Alb::GC transgenic mouse Tg/Tg strain: FVB/N |
H-2 Haplotype | |
ES Cell line | |
Background strain | FVB/N |
Appearance | albino [A/A B/B c/c D/D P/P] |
Strain development | Developed by Drs Seiichi Oyadomari and David Ron, New York University School of Medicine. FVB background. |
Strain description | Alb::GC mice. This transgenic mice express a GADD34 C-terminal fragment (aa 292-590) from a liver-specific albumin promoter. Reduced glucose production in liver is observed. |
Colony maintenance | Carrier x CarrierTg mice are viable and fertile. |
References | Cell Metab., 7, 520-532 (2008). 18522833 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Ppp1r15aprotein phosphatase 1, regulatory (inhibitor) subunit 15AUNPpp1r15aGADD34mouse Albumin enhancer/promoter fragment |
Ordering Information | |
---|---|
Donor DNA | mouse Albumin enhancer/promoter fragment, Hamster GADD34 C-terminal fragment (aa 292-590) |
Research application | |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Cell Metab., 7, 520-532 (2008).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. DEPOSITOR hereby excludes any and all warranties, implied or express, including warranties of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE or of non-infringement of patents or other proprietary right. The sample of BIOLOGICAL RESOURCE is provided "as is". In no event shall DEPOSITOR be liable for direct, indirect, special, incidental or consequential damages in connection with the BIOLOGICAL RESOURCE. RECIPIENT and RIKEN BRC will indemnify and hold DEPOSITOR harmless from any claims or liability resulting from the use of the BIOLOGICAL RESOURCE by you. Prior to filing an application for a patent, or intellectual property or other rights based on the results of research using the BIOLOGICAL RESOURCE, the recipient shall acquire the consent form the DEPOSITOR for such application. |
Depositor | David Ron (New York University School of Medicine) |
Strain Status | Frozen embryos Frozen sperm |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |